Language Selection En
Contact Us
Contact Us
Contact Us
Products / Continence Devices / Bulkamid
Continence Devices

Bulkamid

Bulkamid

Bulkamid is a urethral bulking system for physician-led treatment of female stress urinary incontinence. Within the women's health portfolio, it combines a non-particulate hydrogel with a dedicated delivery system for trained clinical teams.

  • Urethral bulking system containing a water-based hydrogel
  • Minimally invasive application approach
  • Application intended to support urethral coaptation
  • Evaluation within female stress urinary incontinence treatment pathways
  • Patient selection based on specialist physician evaluation
Bulkamid
Bulkamid
Product Overview

A hydrogel and delivery-system relationship

Bulkamid brings the hydrogel, marked needles, measured syringes, and rotatable sheath together as a coordinated urethral bulking system.

Professional understanding depends on distinguishing kit contents from associated cystoscope equipment and following current instructions for patient selection, preparation, delivery, and follow-up.

Technical Product Details

Key technical considerations for Bulkamid evaluation

The technical details connect material composition and delivery components to the way the complete system is prepared and evaluated.

Hydrogel Structure

The product contains a water-based biocompatible hydrogel as defined in the current technical documentation.

Minimally Invasive Application

The hydrogel is placed in the urethral wall using a controlled injection approach.

Urethral Coaptation

The application is intended to support urethral coaptation.

Application System

The delivery system and procedural steps should be evaluated according to the current official instructions for use.

Clinical Use Area

Bulkamid may be considered in selected female stress urinary incontinence treatment pathways.

Patient Suitability

Product suitability is determined according to clinical condition, treatment goals, alternatives, and specialist physician evaluation.

Hydrogel composition

Bulkamid is a non-particulate, homogeneous hydrogel composed of 97.5% water and 2.5% cross-linked polyacrylamide.

Kit configuration

The system kit contains two 1 mL syringes, two 23-gauge 12 cm needles, and one rotatable sheath. The Bulkamid cystoscope is identified separately and is not included in the kit.

System Structure

Bulkamid System Structure

System components and technical functions supporting controlled delivery of the Bulkamid hydrogel

01

Hydrogel Structure

Water-based biocompatible bulking agent composition.

02

Application System

Delivery mechanism designed for controlled injection.

03

Application Approach

System structure supporting controlled delivery of the hydrogel.

04

Urethral Coaptation Support

Structure intended to support continence management mechanisms.

05

Complete Bulkamid System

System components and technical functions supporting controlled delivery of the Bulkamid hydrogel

Professional Support

From product evaluation to professional support

These support pathways help clinical teams move from product understanding to documentation, consultation, and coordinated next steps.

Alignment with the Clinical Plan

The preparation scope is clarified according to the treatment plan and product requirements defined by the clinical team.

01

Product and Supply Preparation

Product supply, application requirements, and current technical documentation are coordinated before the procedure.

02

Application Process Coordination

Technical coordination aligned with the application workflow may be provided when required; clinical decisions and application responsibility remain with the physician.

03

Documentation and Follow-Up

Communication continues for product-related technical questions and documentation needs.

04
Product Knowledge

Bulkamid product knowledge

Use these focused explanations to connect product design, professional context, and the decisions guided by current documentation.

  • Bulkamid may be evaluated in selected female stress urinary incontinence treatment pathways as a minimally invasive urethral bulking option.
Documentation and Related Knowledge

Continue with professional resources

Build on this product overview with selected official literature, professional education, and patient-support materials for Bulkamid.

Patient GuidePublic

Bulkamid patient brochure

Patient education is available from the official product center for clinician-led discussion.

View guide — Can be linked
Technical DocumentationFor PhysiciansPelvic Health and Female Continence
Professional Contact

Request product information and application process support for Bulkamid

Contact Luvi Health for product supply, current technical documentation, and application preparation aligned with the clinical team's plan.

Request Professional Support
Send message